Psychoneuroendocrinology

Psychoneuroendocrinology · ISSN (e) 1873-3360 · 6 papers in corpus
2025
doi:10.1016/j.psyneuen.2025.107584 ·PMID:40902518

Despite decades of research, there is no scientific consensus method for representing the menstrual cycle as a continuous timeline. Common phase- and count-based methods oversimplify hormonal dynamics and overlook individual variability in …

2021
doi:10.1016/j.psyneuen.2021.105154 ·PMID:33647571

In females, pubertal onset appears to signal the opening of a window of increased vulnerability to the effects of stress on neurobehavioral development. What is the impact of pubertal timing on this process? We assessed the effects of puber…

other 2018
doi:10.1016/j.psyneuen.2018.01.001 ·PMID:29414035

Endometriosis is a chronic estrogen-dependent disease in which pelvic pain is the dominant symptom. The negative effects of endometriosis on the life of women with this disease can be a cause of stress. Stress levels can be measured in diff…

2017
doi:10.1016/j.psyneuen.2017.05.015 ·PMID:28550793

Leuprolide acetate (LEU), also known as Lupron, is commonly used to treat prostate cancer in men. As a gonadotropin-releasing hormone (GnRH) receptor agonist, it initially stimulates the release of gonadal hormones, testosterone (T) and est…

2017
doi:10.1016/j.psyneuen.2016.11.029 ·PMID:27987429

Chronic gonadotropin-releasing hormone agonist (GnRHa) administration is used where suppression of hypothalamic-pituitary-gonadal axis activity is beneficial, such as steroid-dependent cancers, early onset gender dysphoria, central precocio…

2013
doi:10.1016/j.psyneuen.2012.06.001 ·PMID:22762895

Endometrial cancer (EC) is the most common type of gynecologic cancer affecting women; however, very little research has examined relationships between psychological factors and hypothalamic-pituitary-adrenal (HPA) axis dysregulation in thi…